BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 16142970)

  • 1. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
    Kim SH; Jeong JH; Chun KW; Park TG
    Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate.
    Hwa Kim S; Hoon Jeong J; Joe CO; Gwan Park T
    J Control Release; 2005 Apr; 103(3):625-34. PubMed ID: 15820409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate receptor-mediated gene delivery using folate-poly(ethylene glycol)-poly(L-lysine) conjugate.
    Cho KC; Kim SH; Jeong JH; Park TG
    Macromol Biosci; 2005 Jun; 5(6):512-9. PubMed ID: 15948228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.
    Wang Y; Wang Y; Xiang J; Yao K
    Biomacromolecules; 2010 Dec; 11(12):3531-8. PubMed ID: 21086982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
    Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
    Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
    Chen J; Li S; Shen Q; He H; Zhang Y
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
    Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
    J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.
    Esmaeili F; Ghahremani MH; Ostad SN; Atyabi F; Seyedabadi M; Malekshahi MR; Amini M; Dinarvand R
    J Drug Target; 2008 Jun; 16(5):415-23. PubMed ID: 18569286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of folate conjugated polymer micelles against different tumor cells.
    Zhao H; Yung LY
    Int J Pharm; 2008 Feb; 349(1-2):256-68. PubMed ID: 17850996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted gene delivery mediated by folate-polyethylenimine-block-poly(ethylene glycol) with receptor selectivity.
    Cheng H; Zhu JL; Zeng X; Jing Y; Zhang XZ; Zhuo RX
    Bioconjug Chem; 2009 Mar; 20(3):481-7. PubMed ID: 19191579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-PEG modified poly(2-(2-aminoethoxy)ethoxy)phosphazene/DNA nanoparticles for gene delivery: synthesis, preparation and in vitro transfection efficiency.
    Zhang P; Zhang Z; Yang Y; Li Y
    Int J Pharm; 2010 Jun; 392(1-2):241-8. PubMed ID: 20298769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modification of PLGA microspheres.
    Müller M; Vörös J; Csúcs G; Walter E; Danuser G; Merkle HP; Spencer ND; Textor M
    J Biomed Mater Res A; 2003 Jul; 66(1):55-61. PubMed ID: 12833431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI.
    Chen TJ; Cheng TH; Hung YC; Lin KT; Liu GC; Wang YM
    J Biomed Mater Res A; 2008 Oct; 87(1):165-75. PubMed ID: 18085650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
    Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
    J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
    Saxena V; Naguib Y; Hussain MD
    Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
    Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
    Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate immobilized and PEGylated adenovirus for retargeting to tumor cells.
    Oh IK; Mok H; Park TG
    Bioconjug Chem; 2006; 17(3):721-7. PubMed ID: 16704210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.